Form D — CeleCor Therapeutics, Inc.
0001705381-26-000006 · filed Jul 9, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Reported offering amount
- $15,000,000
- Reported amount sold
- $11,856,325
- Minimum investment
- $0
- Investors
- 17
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- CeleCor Therapeutics, Inc.
- CIK
- 1705381
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 1155 CAMINO DEL MAR
DEL MAR, CA 92014 - Phone
- 858-777-9750
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Robert S. Hillman, Ph.D. · Executive OfficerDel Mar, CA Find on LinkedIn ↗
-
Andreas Ritzi · DirectorDel Mar, CA Find on LinkedIn ↗
-
Jack Lief · DirectorDel Mar, CA Find on LinkedIn ↗
-
Peter B. Finn · Executive OfficerBoston, MA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗